Abstract
IntroductionSexually transmitted infections (STIs) remain prevalent and are increasing in several populations. Appropriate STI diagnosis is crucial to prevent the transmission and sequelae of untreated infection. We reviewed the diagnostic accuracy of syndromic case management and existing point‐of‐care tests (POCTs), including those in the pipeline, to diagnose STIs in resource‐constrained settings.MethodsWe prioritized updating the systematic review and meta‐analysis of the diagnostic accuracy of vaginal discharge from 2001 to 2015 to include studies until 2018. We calculated the absolute effects of different vaginal flowcharts and the diagnostic performance of POCTs on important outcomes. We searched the peer‐reviewed literature for previously conducted systematic reviews and articles from 1990 to 2018 on the diagnostic accuracy of syndromic management of vaginal and urethral discharge, genital ulcer and anorectal infections. We conducted literature reviews from 2000 to 2018 on the existing POCTs and those in the pipeline.Results and discussionsThe diagnostic accuracy of urethral discharge and genital ulcer disease syndromes is relatively adequate. Asymptomatic Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections limit the use of vaginal discharge and anorectal syndromes. The pooled diagnostic accuracy of vaginal syndromic case management for CT/NG is low, resulting in high numbers of overtreatment and missed treatment. The absolute effect of POCTs was reduced overtreatment and missed treatment. Findings of the reviews on syndromic case management underscored the need for low‐cost and accurate POCTs for the identification, first, of CT/NG, and, second, of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) and NG and MG resistance/susceptibility testing. Near‐patient POCT molecular assays for CT/NG/TV are commercially available. The prices of these POCTs remain the barrier for uptake in resource‐constrained settings. This is driving the development of lower cost solutions.ConclusionsThe WHO syndromic case management guidelines should be updated to raise the quality of STI management through the integration of laboratory tests. STI screening strategies are needed to address asymptomatic STIs. POCTs that are accurate, rapid, simple and affordable are urgently needed in resource‐constrained settings to support the uptake of aetiological diagnosis and treatment.
Highlights
Transmitted infections (STIs) remain prevalent and are increasing in several populations
One Food and Drug Administration (FDA)-approved near-patient (POCT) molecular assay (Xpert Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG)) is available to distinguish between CT and NG, the cost and other limitations [75,101] remain prohibitive for use in primary care
The available evidence on the effectiveness and challenges of syndromic case management further underscores the need to scale up existing STI diagnostics and the development of point-of-care tests (POCTs) for, first, the identification of CT/ NG, but ideally Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV), as well as NG and MG antimicrobial resistance (AMR) in vaginal, urethral and anorectal discharge
Summary
Transmitted infections (STIs) remain prevalent and are increasing in several populations. We reviewed the diagnostic accuracy of syndromic case management and existing point-of-care tests (POCTs), including those in the pipeline, to diagnose STIs in resource-constrained settings. We searched the peer-reviewed literature for previously conducted systematic reviews and articles from 1990 to 2018 on the diagnostic accuracy of syndromic management of vaginal and urethral discharge, genital ulcer and anorectal infections. Near-patient POCT molecular assays for CT/NG/TV are commercially available The prices of these POCTs remain the barrier for uptake in resource-constrained settings. STI screening strategies are needed to address asymptomatic STIs. POCTs that are accurate, rapid, simple and affordable are urgently needed in resource-constrained settings to support the uptake of aetiological diagnosis and treatment. In resource-constrained settings, aetiological diagnosis of STIs remains difficult due to limited access to laboratory diagnostics to guide appropriate treatment [8].
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have